Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Aquinnah Pharmaceuticals
700 Main Street
North Cambridge, MA 02139

Aquinnah Pharmaceuticals is using newly discovered brain pathology to design innovative therapies to slow the progression of ALS and other neurodegenerative diseases. Aquinnah builds on the groundbreaking work of co-founder Benjamin Wolozin, M.D., Ph.D., who has led the discovery of disease-linked protein aggregation in neurologic diseases.

Key Contact
Name
Glenn Larsen
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/21/15 $5,000,000 Strategic Takeda Ventures
undisclosed